Výsledky vyhledávání - "Craig A. Vargo"

Data from The role of vascular endothelial growth factor SNPs as predictive and prognostic markers for major solid tumors

Autor: William D. Figg, Jürgen Venitz, David Venzon, Douglas K. Price, Tristan M. Sissung, Romano Danesi, Craig A. Vargo, Lokesh Jain

Angiogenesis is crucial for development and metastasis of tumors, and vascular endothelial growth factor (VEGF) is a key mediator of this process. The importance of VEGF in tumorigenesis and tumor progression makes it an attractive target for the dev

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::99165b340af04bb0771f202b99aafd72
https://doi.org/10.1158/1535-7163.c.6532077

Zobrazit plný text záznamu

Abstract PS13-46: Immunomodulation with dexamethasone in neoadjuvant chemotherapy for triple negative breast cancer

Autor: Sagar Sardesai, Michael F. Berger, Abdul Miah, Patrick Schnell, Dionisia Quiroga, Daniel Goldstein, Craig A. Vargo, Bhuvaneswari Ramaswamy, Nicole Williams, Namrata Vilas Shinde, Mahmoud Kassem, Gary Tozbikian, Maryam B. Lustberg, Mathew Cherian, Daniel G. Stover

Publikováno v: Cancer Research. 81:PS13-46

Introduction: The immunomodulatory effects of dexamethasone and prednisone have been a staple of chemotherapy regimens since Mustargen, Oncovin, procarbazine, prednisone (MOPP) was used to treat lymphomas in 1963. Since then steroids have become ubiq

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d88dedc440d3b2c7ae66366468997ec1
https://doi.org/10.1158/1538-7445.sabcs20-ps13-46

Zobrazit plný text záznamu

Progression-Free Survival for Real-World Use of Palbociclib in Hormone Receptor-Positive Metastatic Breast Cancer

Autor: Robert Wesolowski, Junan Li, Raquel E. Reinbolt, Bhuvaneswari Ramaswamy, Jonathan Wilkie, Craig A. Vargo, Sagar Sardesai, Anne M. Noonan, Michael Berger, M. Alexandra Schickli, Nicole Williams, Maryam B. Lustberg, Daniel G. Stover, Jeffrey VanDeusen

Publikováno v: Clinical Breast Cancer. 20:33-40

Background Additional use of cyclin-dependent kinase 4/6 inhibitors with endocrine therapy improves progression-free survival (PFS) in advanced hormone receptor (HR)-positive HER2-negative breast cancer. However, neutropenia is a common reason for do

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a88dbe4a5181cc857b6e5be6a5a0ca5
https://doi.org/10.1016/j.clbc.2019.06.010

Zobrazit plný text záznamu

Efficacy of different dosing schedules of capecitabine for metastatic breast cancer: a single-institution experience

Autor: Akannsha Ganju, Robert Wesolowski, Evan Morgan, Raquel E. Reinbolt, Marilly Palettas, Maryam B. Lustberg, Michael Berger, Anupama Suresh, Daniel G. Stover, Mathew Cherian, Jeffrey VanDeusen, Joseph Liu, Sagar Sardesai, Julie A. Stephens, Anne M. Noonan, Nicole Williams, Bhuvaneswari Ramaswamy, Craig A. Vargo

Publikováno v: Investigational New Drugs. 38:1605-1611

Purpose Capecitabine is widely used as a single agent on a 21-day cycle in the management of metastatic breast cancer (MBC). Our primary objective was to compare the standard dosing of capecitabine (Arm A: days 1–14 on 21-day cycle) to biweekly dos

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4e671f2d8681f09d752673c7f748a130
https://doi.org/10.1007/s10637-020-00891-9

Zobrazit plný text záznamu

CLO19-027: Assessment of Metastatic Invasive Lobular Carcinoma Management and Outcomes From 2004-2014: A Single Institution Experience

Autor: Robert Wesolowski, Julie A. Stephens, Hinda Boutrid, Marilly Palettas, Sagar Sardesai, Nicole Williams, Evan Morgan, Mohmoud Kassem, Michael Berger, Maryam B. Lustberg, Mathew Cherian, Daniel G. Stover, Jeffrey VanDeusen, Bhuvaneswari Ramaswamy, Craig A. Vargo

Publikováno v: Journal of the National Comprehensive Cancer Network. 17:CLO19-027

Background: Invasive lobular carcinoma (ILC) accounts for 5%–15% of all invasive breast cancer cases. ILC has the propensity for distant late recurrence with widespread metastatic disease. To our knowledge, there is limited data on the clinical out

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::9b1b41044cb24a1f98add75e47b97326
https://doi.org/10.6004/jnccn.2018.7251

Zobrazit plný text záznamu

Comparison of subsequent infusion hypersensitivity reactions to paclitaxel using two different infusion strategies

Autor: Stephanie Folan, Michael Berger, Junan Li, Kristen Nymberg, Kyle Zanath, Craig A. Vargo, Jeffrey VanDeusen

Publikováno v: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 29(8)

The purpose of this study was to compare the incidence of rescue medication utilization with up to 3 subsequent doses of paclitaxel in patients who underwent an infusion rate escalation versus those who continued on the standard infusion rate after e

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c7c96d29b30bdabacd6fad409cd95b4
https://pubmed.ncbi.nlm.nih.gov/33447864

Zobrazit plný text záznamu

Abstract OT2-05-03: Does minocycline mitigate chemotherapy induced neuroinflammation? A phase II randomized placebo controlled study

Autor: H Boutrid, Michael V. Knopp, Sagar Sardesai, E Gleich, Robert Wesolowski, AC DeVries, B Ramaswamy, Michael F. Berger, L Flora, Anne M. Noonan, R Reinbolt, Maryam B. Lustberg, Craig A. Vargo, Xueliang Pan, Nita Williams, Jeffrey VanDeusen

Publikováno v: Cancer Research. 78:OT2-05

Background: Many breast cancer (BC) patients, particularly those who receive chemotherapy (chemo), experience affective symptoms and cognitive changes that can negatively impact their quality of life. Causal links between inflammatory mediators and t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::0c32d7932b9903268ff5795410cb9059
https://doi.org/10.1158/1538-7445.sabcs17-ot2-05-03

Zobrazit plný text záznamu

Pathological complete response rates with pertuzumab-based neoadjuvant chemotherapy in breast cancer: A single-center experience

Autor: Kristen Nymberg, Bhuvaneswari Ramaswamy, Michael Berger, Robert Wesolowski, Sagar Sardesai, Christina M Matthews, Junan Li, Craig A. Vargo, Maryam B. Lustberg, Jessica Dempsey, Nicole Williams, Raquel E. Reinbolt

Publikováno v: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners. 26(3)

Background Pertuzumab-based neoadjuvant chemotherapy (NAC) has demonstrated successful pathologic complete response (pCR) rates when administered to patients with human epidermal growth factor receptor 2 (HER2)-positive, locally advanced breast cance

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::121e32f52385094abf25ab906c2c9f3d
https://pubmed.ncbi.nlm.nih.gov/31256745

Zobrazit plný text záznamu

Association of pathological complete response rates and TILs in triple-negative breast cancer patients

Publikováno v: Journal of Clinical Oncology. 39:e12596-e12596

e12596 Background: Triple negative breast cancers (TNBC), characterized by the lack of expression of estrogen receptors and progesterone receptors as well as human epidermal growth factor receptor 2, are associated with high distant recurrence rate a

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::70cd0ef97e4cb9b0da3661fb034ab190
https://doi.org/10.1200/jco.2021.39.15_suppl.e12596

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání